You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Post-Essential Thrombocythemia Myelofibrosis (PET-MF)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib)

Completed
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +37 more
Jan 17, 2020

Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

Terminated
  • Essential Thrombocythemia
  • +3 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Aug 10, 2020

Assess Real-World Patient-Reported Outcomes With Fedratinib for

Recruiting
  • Myelofibrosis
    • City, State, Austria
      Local Institution
    Dec 16, 2022

    Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

    Not yet recruiting
    • Essential Thrombocythemia
    • (no location specified)
    Oct 6, 2023

    Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia:

    Completed
    • Polycythemia Vera
    • +2 more
      • Salt Lake City, Utah
        University of Utah
      Oct 14, 2019

      Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Terminated
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Scottsdale, Arizona
      • +121 more
      Oct 21, 2021

      Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

      Not yet recruiting
      • Essential Thrombocythemia
      • Ropeginterferon alfa-2b-njft (P1101)
      • (no location specified)
      Jul 28, 2022

      Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Completed
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Vienna, Austria
      • +19 more
      Apr 28, 2020

      Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

      Completed
      • Primary Myelofibrosis
      • +2 more
      • Phoenix, Arizona
      • +113 more
      Apr 13, 2020

      Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

      Recruiting
      • Myelofibrosis
      • +3 more
      • Berkeley, California
      • +176 more
      Dec 1, 2022

      Philadelphia Negative Myeloproliferative Tumors Trial

      Not yet recruiting
      • Philadelphia Negative Myeloproliferative Neoplasms
        • (no location specified)
        Jun 5, 2022

        Primary Myelofibrosis (MF), Post-Polycythemia Vera (PV) MF, Post-Essential Thrombocythemia (ET) MF Trial in Worldwide

        Completed
        Has Results
        • Primary Myelofibrosis (MF)
        • +2 more
        • Beijing, Beijing, China
        • +25 more
        Aug 29, 2019

        Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

        Recruiting
        • Myelofibrosis
        • Hematopoietic Stem Cell Transplant
        • Minneapolis, Minnesota
          Center for International Blood and Marrow Transplant Research
        Mar 17, 2022

        Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary

        Withdrawn
        • Myelofibrosis Transformation in Essential Thrombocythemia
        • +2 more
        • LOXL2 Inhibitor PAT-1251
        • +2 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 9, 2019

        Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

        Terminated
        Has Results
        • Primary Myelofibrosis
        • +2 more
        • Scottsdale, Arizona
        • +80 more
        Sep 25, 2020

        Myelofibrosis (MF) Trial in Worldwide (Ruxolitinib, Navitoclax)

        Active, not recruiting
        • Myelofibrosis (MF)
        • Birmingham, Alabama
        • +149 more
        Nov 5, 2021

        Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

        Recruiting
        • Myelofibrosis
        • +3 more
        • Birmingham, Alabama
        • +13 more
        Jan 10, 2023

        Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)

        Active, not recruiting
        • Chronic Myeloproliferative Neoplasms
        • Berlin, Germany
        • +14 more
        Jun 14, 2021

        Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))

        Recruiting
        • Myelofibrosis
        • La Jolla, California
        • +165 more
        Aug 19, 2022

        Myeloproliferative Tumors (MPN), Polycythemia Vera (PV), Essential Thrombocythemia (ET) Trial in Toronto (Upper gastrointestinal

        Completed
        • Myeloproliferative Neoplasms (MPN)
        • +3 more
        • Upper gastrointestinal endoscopy and Doppler ultrasound
        • Toronto, Ontario, Canada
        • +1 more
        Dec 12, 2019

        Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)

        Completed
        Has Results
        • Primary Myelofibrosis
        • +9 more
        • Camperdown, New South Wales, Australia
        • +17 more
        Apr 3, 2020

        ARDS, Human, COVID Trial in Marburg (Ruxolitinib administration)

        Completed
        • ARDS, Human
        • COVID
        • Ruxolitinib administration
        • Marburg, Germany
          Andreas Neubauer
        Aug 23, 2021

        Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

        Completed
        Has Results
        • Myelofibrosis
        • Imetelstat 4.7 mg/kg
        • Imetelstat 9.4 mg/kg
        • Birmingham, Alabama
        • +71 more
        Aug 17, 2021

        Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

        Active, not recruiting
        • Myelofibrosis
        • Polycythemia Vera
        • Phoenix, Arizona
        • +4 more
        Jun 20, 2022

        Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (CC-4047)

        Completed
        Has Results
        • Chronic Myeloproliferative Disorders
        • Secondary Myelofibrosis
        • Rochester, Minnesota
          Mayo Clinic
        Dec 16, 2019